Literature DB >> 13872176

The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes.

S BOYDEN.   

Abstract

An in vitro technique is described for assessing the chemotactic activity of soluble substances on motile cells. Antibody-antigen mixtures when incubated (37 degrees C) in medium containing fresh (i.e. non-inactivated) normal rabbit serum exert a strong chemotactic effect on rabbit polymorphonuclear leucocytes. Results are described which indicate that, when antibody-antigen complexes are incubated (37 degrees C) in fresh serum, a heat-stable (56 degrees C) substance (or substances) is produced which acts directly as a chemotactic stimulus on the polymorphs. This heat-stable chemotactic substance is not produced when antibody-antigen complexes are incubated in serum which has been heated at 56 degrees C for 30 minutes.

Entities:  

Keywords:  ANTIBODIES; ANTIGENS; LEUKOCYTES/chemistry

Mesh:

Substances:

Year:  1962        PMID: 13872176      PMCID: PMC2137509          DOI: 10.1084/jem.115.3.453

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  4 in total

1.  Cellular associations in normal and abnormal lymphocytes.

Authors:  R J PULVERTAFT
Journal:  Proc R Soc Med       Date:  1959-05

2.  Studies on mouse lymphomas. II. Behavior of three lymphomas in diffusion chambers in relation to their invasive capacity in the host.

Authors:  E SHELTON; M E RICH
Journal:  J Natl Cancer Inst       Date:  1958-07       Impact factor: 13.506

3.  Role of chemotaxis in inflammation.

Authors:  H HARRIS
Journal:  Physiol Rev       Date:  1954-07       Impact factor: 37.312

4.  Studies of phagocytosis of group A streptococci by polymorphonuclear leucocytes in vitro.

Authors:  J G HIRSCH; A B CHURCH
Journal:  J Exp Med       Date:  1960-03-01       Impact factor: 14.307

  4 in total
  667 in total

1.  Enhanced chemotaxis of macrophages by strenuous exercise in trained mice: thyroid hormones as possible mediators.

Authors:  E Ortega; M A Forner; J J Garcia; A B Rodriguez; C Barriga
Journal:  Mol Cell Biochem       Date:  1999-11       Impact factor: 3.396

Review 2.  Factors influencing airway inflammation in chronic obstructive pulmonary disease.

Authors:  A Hill; S Gompertz; R Stockley
Journal:  Thorax       Date:  2000-11       Impact factor: 9.139

3.  Comparison of leukocyte count and function in smoking and nonsmoking young men.

Authors:  R C Noble; B B Penny
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

4.  Reversible granulocyte killing defect in anorexia nervosa.

Authors:  F M Gotch; C J Spry; A G Mowat; P B Beeson; I C Maclennan
Journal:  Clin Exp Immunol       Date:  1975-08       Impact factor: 4.330

5.  Suppression of leukocyte chemotaxis in vitro by chemotherapeutic agents used in the management of thermal injuries.

Authors:  G D Warden; A D Mason; B A Pruitt
Journal:  Ann Surg       Date:  1975-03       Impact factor: 12.969

6.  [Granulocyte dysfunction. Part II. Secondary defects. (authors transl)].

Authors:  D Niethammer; A Wildfeuer; E Kleihauer; O Haferkamp
Journal:  Klin Wochenschr       Date:  1975-08-15

7.  [The chemotactic effect of blister roof, blister fluid and blister floor on polymorphonuclear leucocytes in dermatitis herpetiformis Duhring (author's transl)].

Authors:  K Bork
Journal:  Arch Dermatol Forsch       Date:  1975

Review 8.  Slit proteins, potential endogenous modulators of inflammation.

Authors:  Necat Havlioglu; Liya Yuan; Hao Tang; Jane Y Wu
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

Review 9.  Neuronal migration and molecular conservation with leukocyte chemotaxis.

Authors:  Yi Rao; Kit Wong; Michael Ward; Claudia Jurgensen; Jane Y Wu
Journal:  Genes Dev       Date:  2002-12-01       Impact factor: 11.361

10.  Inflammatory effects of phthalates in neonatal neutrophils.

Authors:  Anna M Vetrano; Debra L Laskin; Faith Archer; Kirin Syed; Joshua P Gray; Jeffrey D Laskin; Nkiru Nwebube; Barry Weinberger
Journal:  Pediatr Res       Date:  2010-08       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.